Levetiracetam 250mg Tablets

Levetiracetam 250mg is an antiepileptic used to prevent seizures, including focal-onset seizures and, in appropriate treatment combinations, myoclonic and generalised tonic-clonic seizures. It provides ongoing seizure control rather than stopping an active prolonged seizure.
Conventional tablets are usually taken in two evenly spaced daily doses, with or without food. Swallow with water and take doses at consistent times. A gradual dose increase can improve tolerability. Withdrawal is also gradual because sudden interruption can increase seizure frequency.
Levetiracetam binds to the synaptic vesicle protein SV2A, which helps regulate release of chemical signals between nerve cells. This reduces abnormal, excessive electrical activity associated with seizures.
Sleepiness, dizziness, tiredness, headache and irritability can occur. Marked aggression, depression, thoughts of self-harm, a severe rash or worsening seizures need prompt medical attention.
Kidney impairment can require a lower dose. Tell your doctor about previous depression or behavioural changes, pregnancy plans and other sedating medicines. Avoid driving while sleepy or dizzy. Macrogol laxatives should be separated from levetiracetam by at least one hour before and after the dose.
Reduces seizure frequency and can help maintain more stable seizure control when taken regularly. It can be used alone or with other antiepileptics depending on seizure type and age.
Yes. Irritability or aggression can appear after starting treatment or increasing the dose. A family member may notice the change first; significant mood changes should be reported promptly.
Being seizure-free may mean the treatment is working, not that epilepsy has resolved. A planned, gradual withdrawal depends on seizure history and the risk of recurrence.
They have different release patterns and may use different dosing schedules. The same milligram strength does not mean the same tablet-taking schedule.
Arrange an early epilepsy review without abruptly stopping treatment. Seizure control, folic acid needs and drug exposure can require closer monitoring during pregnancy.
Focal seizure: a seizure beginning in one area of the brain; Myoclonus: a brief involuntary muscle jerk; Tonic-clonic seizure: a seizure with stiffening and rhythmic jerking; SV2A: a synaptic vesicle protein involved in nerve-signal release; Antiepileptic: a medicine that reduces seizure occurrence; AR: Levetiracetam 250mg أقراص; FR: Levetiracetam 250mg comprimés; PT: Levetiracetam 250mg comprimidos; ES: Levetiracetam 250mg comprimidos; RU: Levetiracetam 250mg таблетки; ID: Levetiracetam 250mg tablet; VI: Levetiracetam 250mg viên nén; MS: Levetiracetam 250mg tablet; TL: Levetiracetam 250mg tableta; ZH-SG: Levetiracetam 250mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Levetiracetam 250mg Tablets under Neuro Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Levetiracetam 250mg Tablets